PL341697A1 - Compositions derived from mycobacterium vaccae and methods of using them - Google Patents
Compositions derived from mycobacterium vaccae and methods of using themInfo
- Publication number
- PL341697A1 PL341697A1 PL98341697A PL34169798A PL341697A1 PL 341697 A1 PL341697 A1 PL 341697A1 PL 98341697 A PL98341697 A PL 98341697A PL 34169798 A PL34169798 A PL 34169798A PL 341697 A1 PL341697 A1 PL 341697A1
- Authority
- PL
- Poland
- Prior art keywords
- methods
- compositions derived
- mycobacterium vaccae
- vaccae
- mycobacterium
- Prior art date
Links
- 241000187644 Mycobacterium vaccae Species 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US99662497A | 1997-12-23 | 1997-12-23 | |
US08/997,362 US5985287A (en) | 1996-08-29 | 1997-12-23 | Compounds and methods for treatment and diagnosis of mycobacterial infections |
US08/997,080 US5968524A (en) | 1997-12-23 | 1997-12-23 | Methods and compounds for the treatment of immunologically-mediated psoriasis |
US09/095,855 US6160093A (en) | 1996-08-29 | 1998-06-11 | Compounds and methods for treatment and diagnosis of mycobacterial infections |
US15618198A | 1998-09-17 | 1998-09-17 | |
US09/205,426 US6406704B1 (en) | 1996-08-29 | 1998-12-04 | Compounds and methods for treatment and diagnosis of mycobacterial infections |
Publications (1)
Publication Number | Publication Date |
---|---|
PL341697A1 true PL341697A1 (en) | 2001-04-23 |
Family
ID=27557521
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL98341697A PL341697A1 (en) | 1997-12-23 | 1998-12-23 | Compositions derived from mycobacterium vaccae and methods of using them |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1044273A2 (fr) |
JP (1) | JP2002514385A (fr) |
CN (1) | CN1294632A (fr) |
AU (1) | AU746311B2 (fr) |
BR (1) | BR9814432A (fr) |
CA (1) | CA2315539A1 (fr) |
HU (1) | HUP0100352A2 (fr) |
ID (1) | ID26327A (fr) |
IL (1) | IL136821A0 (fr) |
MX (1) | MXPA00006168A (fr) |
NO (1) | NO20003261L (fr) |
NZ (1) | NZ505834A (fr) |
PL (1) | PL341697A1 (fr) |
TR (1) | TR200001948T2 (fr) |
WO (1) | WO1999032634A2 (fr) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6569436B1 (en) | 1998-10-05 | 2003-05-27 | The Malaghan Institute Of Medical Research | Method of using a vaccine |
JP4415200B2 (ja) * | 1999-01-29 | 2010-02-17 | 大塚製薬株式会社 | 遅発育性抗酸菌ポリペプチド |
GB9903539D0 (en) | 1999-02-16 | 1999-04-07 | Stanford Rook Ltd | Therapy using M.Vaccae |
US6350457B1 (en) * | 1999-06-02 | 2002-02-26 | Genesis Research & Development Corporation Limited | Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae |
MXPA01013097A (es) * | 1999-07-12 | 2002-06-04 | Genesis Res & Dev Corp Ltd | Compuestos para el tratamiento del sistema infeccioso e inmune y metodos para su uso.. |
EP1214426A2 (fr) | 1999-08-31 | 2002-06-19 | Novozymes A/S | Nouvelles proteases et leurs variants |
AU7901300A (en) * | 1999-08-31 | 2001-03-26 | Stefan Bossmann | Method for producing a channel-forming protein |
US7217554B2 (en) | 1999-08-31 | 2007-05-15 | Novozymes A/S | Proteases and variants thereof |
US6361776B1 (en) * | 1999-12-06 | 2002-03-26 | Genesis Research & Development Corp. Ltd. | Compounds isolated from M. vaccae and their use in modulation of immune responses |
US20030108527A1 (en) * | 1999-12-28 | 2003-06-12 | Tsukasa Seya | Maturation-promoting agent for immature dendrtic cells |
AUPQ761200A0 (en) | 2000-05-19 | 2000-06-15 | Hunter Immunology Limited | Compositions and methods for treatment of mucosal infections |
AU2002309857A1 (en) * | 2001-05-11 | 2002-12-03 | Corixa Corporation | Vaccines for the treatment of autoimmune disease |
US20030147861A1 (en) * | 2001-07-26 | 2003-08-07 | Genesis Research And Development Corporation Limited | Compounds and methods for the modulation of immune responses |
AU2002353366A1 (en) * | 2001-12-10 | 2003-06-23 | Bakulesh Mafatlal Khamar | The process of manufacturing a pharmaceutical composition useful for management of cancer |
GB0303507D0 (en) * | 2003-02-14 | 2003-03-19 | Novartis Ag | Organic compounds |
WO2015104380A1 (fr) * | 2014-01-09 | 2015-07-16 | Transgene Sa | Fusion d'antigènes mycobactériens hétérooligomères |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8919321D0 (en) * | 1989-08-25 | 1989-10-11 | Univ London | Treatment of chronic inflammatory conditions |
GB9203814D0 (en) * | 1992-02-21 | 1992-04-08 | Univ London | Treatment of long term auto-immune conditions |
US6284255B1 (en) * | 1996-08-29 | 2001-09-04 | Genesis Research & Development Corporation Limited | Compounds and methods for treatment and diagnosis of mycobacterial infections |
-
1998
- 1998-12-23 ID IDW20001433A patent/ID26327A/id unknown
- 1998-12-23 CA CA002315539A patent/CA2315539A1/fr not_active Abandoned
- 1998-12-23 JP JP2000525553A patent/JP2002514385A/ja active Pending
- 1998-12-23 MX MXPA00006168A patent/MXPA00006168A/es unknown
- 1998-12-23 HU HU0100352A patent/HUP0100352A2/hu unknown
- 1998-12-23 EP EP98963665A patent/EP1044273A2/fr not_active Withdrawn
- 1998-12-23 NZ NZ505834A patent/NZ505834A/xx unknown
- 1998-12-23 TR TR2000/01948T patent/TR200001948T2/xx unknown
- 1998-12-23 BR BR9814432-4A patent/BR9814432A/pt not_active IP Right Cessation
- 1998-12-23 IL IL13682198A patent/IL136821A0/xx unknown
- 1998-12-23 WO PCT/NZ1998/000189 patent/WO1999032634A2/fr not_active Application Discontinuation
- 1998-12-23 CN CN98813781A patent/CN1294632A/zh active Pending
- 1998-12-23 PL PL98341697A patent/PL341697A1/xx unknown
- 1998-12-23 AU AU18936/99A patent/AU746311B2/en not_active Ceased
-
2000
- 2000-06-22 NO NO20003261A patent/NO20003261L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ID26327A (id) | 2000-12-14 |
CA2315539A1 (fr) | 1999-07-01 |
AU746311B2 (en) | 2002-04-18 |
BR9814432A (pt) | 2000-10-10 |
NZ505834A (en) | 2002-12-20 |
AU1893699A (en) | 1999-07-12 |
MXPA00006168A (es) | 2005-02-24 |
IL136821A0 (en) | 2001-06-14 |
JP2002514385A (ja) | 2002-05-21 |
NO20003261L (no) | 2000-08-22 |
EP1044273A2 (fr) | 2000-10-18 |
HUP0100352A2 (hu) | 2001-06-28 |
WO1999032634A2 (fr) | 1999-07-01 |
WO1999032634A3 (fr) | 1999-12-02 |
TR200001948T2 (tr) | 2001-02-21 |
CN1294632A (zh) | 2001-05-09 |
NO20003261D0 (no) | 2000-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL339261A1 (en) | Elastomeric compositions and method of obtaining them | |
PL317060A1 (en) | Binder composition, method of obtaining same and method of using such binder composition | |
PL341697A1 (en) | Compositions derived from mycobacterium vaccae and methods of using them | |
PL337531A1 (en) | Compositions for and methods of inhibiting photo-ageing of skin | |
PL332699A1 (en) | Immunomodulation methods and compositions | |
PL327658A1 (en) | Disinfecting compositions and methods of disinfecting surfaces | |
PL333364A1 (en) | Novel compounds and method of using them | |
HUP9904074A3 (en) | Moniliformin detoxification compositions and methods | |
ZA989399B (en) | Method and composition | |
HUP9903577A3 (en) | Beauvericin detoxification compositions and methods | |
PL332415A1 (en) | Ore cleaning compositions and methods | |
EP1056456A4 (fr) | Compositions et procedes d'utilisation du r-lansoprazole | |
PL339619A1 (en) | Compositions containing copolymers of polyphenoles and method of obtaining such compositions | |
PL327945A1 (en) | Disinfecting compositions and methods of disinfecting surfaces | |
ZA989398B (en) | Method and composition (l) | |
EP1056457A4 (fr) | Compositions de s-lansoprazole et procedes d'utilisation | |
EP1036165A4 (fr) | Rnase humaine, compositions et leurs utilisations | |
GB9624501D0 (en) | Insecticial compositions and method | |
EP1073333A4 (fr) | Compositions a base de s-rabeprazole et procedes | |
EP1139981A4 (fr) | Compositions et procedes d'utilisation associes | |
PL329122A1 (en) | Pesticidal compositions of ciprodinyl and myclobutanil or yprodione | |
PL337716A1 (en) | Method of obtaining thiazafurin and other c-nucleosides | |
IL120488A (en) | Modifiers for water-setting inorganic compositions and modified water-setting inorganic compositions | |
GB9621533D0 (en) | Composition and method | |
PL334316A1 (en) | Compositions and polymorphous forms of desferrioxyamine and method of obtaining them |